Merck & Co., Inc.MRKNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank72
3Y CAGR-6.4%
5Y CAGR-35.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-6.4%/yr
Quarterly compound
5Y CAGR
-35.8%/yr
Recent acceleration
Percentile
P72
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.43% |
| Q3 2025 | -0.60% |
| Q2 2025 | 3.80% |
| Q1 2025 | -5.17% |
| Q4 2024 | -1.46% |
| Q3 2024 | -0.29% |
| Q2 2024 | 10.31% |
| Q1 2024 | -5.98% |
| Q4 2023 | 4.84% |
| Q3 2023 | -6.77% |
| Q2 2023 | 9.00% |
| Q1 2023 | -7.74% |
| Q4 2022 | 6.63% |
| Q3 2022 | 0.32% |
| Q2 2022 | 8.14% |
| Q1 2022 | -17.92% |
| Q4 2021 | 21.15% |
| Q3 2021 | 2.41% |
| Q2 2021 | 4.30% |
| Q1 2021 | -29.11% |
| Q4 2020 | 49.76% |
| Q3 2020 | -1.20% |
| Q2 2020 | -18.40% |
| Q1 2020 | -11.56% |
| Q4 2019 | 11.59% |
| Q3 2019 | -4.54% |
| Q2 2019 | 11.84% |
| Q1 2019 | -8.25% |
| Q4 2018 | 8.19% |
| Q3 2018 | -2.59% |
| Q2 2018 | 0.00% |
| Q1 2018 | -2.75% |
| Q4 2017 | 4.88% |
| Q3 2017 | -1.64% |
| Q2 2017 | 1.13% |
| Q1 2017 | -4.67% |
| Q4 2016 | 8.36% |
| Q3 2016 | -2.64% |
| Q2 2016 | 6.04% |
| Q1 2016 | -11.36% |